STEPHEN HARRIS: Open Payments
NPI 1821195637 · PHILIPPI, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$906 in 49 payments from 11 companies in 2025. Trend: 2023 $397 · 2024 $744 · 2025 $906
Food & beverage: $906
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $198 |
| Novo Nordisk Inc | 9 | $174 |
| AstraZeneca Pharmaceuticals LP | 6 | $154 |
| PFIZER INC. | 6 | $123 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $76 |
| Verona Pharma, Inc. | 2 | $43 |
| Lilly USA, LLC | 2 | $41 |
| Exact Sciences Corporation | 2 | $33 |
| Phathom Pharmaceuticals, Inc. | 1 | $28 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
Products named: AIRSUPRA, Ozempic, VRAYLAR, ELIQUIS, Kerendia, UBRELVY, Rybelsus, Ohtuvayre.
Industry payments across WV — which companies pay providers there.
